IPP-2 (phospho Ser120/S121) Polyclonal Antibody

Rabbit Anti-IPP-2 (phospho Ser120/S121) Polyclonal Antibody

Product Specifications

Background

Protein phosphatase-1 (PP1) is one of the main eukaryotic serine/threonine phosphatases. The protein encoded by PPP1R2 (protein phosphatase 1 regulatory inhibitor subunit 2) binds to the catalytic subunit of PP1, strongly inhibiting its activity. Ten related pseudogenes have been found throughout the human genome. Several splice variants encoding different isoforms have been found for this gene.

CAS Number

9007-83-4

Product Name Alternative

PPP1R2; IPP2; Protein phosphatase inhibitor 2; IPP-2

Gene ID

5504

Accession Number

P41236

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from human IPP-2 around the phosphorylation site of S120/S121

Clonality

Polyclonal

Tag

Protein phosphatase inhibitor 2

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Phospho-IPP-2 (S120/S121) Polyclonal Antibody detects endogenous levels of IPP-2 protein only when phosphorylated at S120/S121.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200